Publications
Found 5 results
Filters: Author is J. Xiao [Clear All Filters]
, “Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma”, vol. 14, pp. 6943-6952, 2015.
, “Effect of skeletal muscle fibers on porcine meat quality at different stages of growth”, vol. 14, pp. 7873-7882, 2015.
, “Association of XRCC5 polymorphisms with COPD and COPD-related phenotypes in the Han Chinese population: a case-control cohort study”, vol. 13, pp. 7070-7078, 2014.
, “Higher expression of acyl-CoA dehydrogenase genes in adipose tissues of obese compared to lean pig breeds”, vol. 13, pp. 1684-1689, 2014.
, “Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma”, vol. 12, pp. 1045-1053, 2013.
Athanassiadou P, Grapsa D, Athanassiades P, Gonidi M, et al. (2008). The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol. Res. Pract. 204: 241-249.
http://dx.doi.org/10.1016/j.prp.2007.11.004
PMid:18171606
Celen O, Kahraman I, Yildirim E and Berberoglu U (2004). Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51: 293-299.
PMid:15254661
Deveraux QL and Reed JC (1999). IAP family proteins - suppressors of apoptosis. Genes Dev. 13: 239-252.
http://dx.doi.org/10.1101/gad.13.3.239
PMid:9990849
Fleshner NE, Herr HW, Stewart AK, Murphy GP, et al. (1996). The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 78: 1505-1513.
http://dx.doi.org/10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3
Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, et al. (2003). Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 88: 115-119.
http://dx.doi.org/10.1038/sj.bjc.6600696
PMid:12556969 PMCid:2376783
Ikeguchi M, Ueda T, Sakatani T, Hirooka Y, et al. (2002). Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn. Mol. Pathol. 11: 33-40.
http://dx.doi.org/10.1097/00019606-200203000-00007
PMid:11854600
Islam A, Kageyama H, Takada N, Kawamoto T, et al. (2000). High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623.
http://dx.doi.org/10.1038/sj.onc.1203358
PMid:10698506
Jin Q, Hemminki K, Enquist K, Lenner P, et al. (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res. 11: 3647-3653.
http://dx.doi.org/10.1158/1078-0432.CCR-04-1803
PMid:15897560
Kirkali Z, Chan T, Manoharan M, Algaba F, et al. (2005). Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66: 4-34.
http://dx.doi.org/10.1016/j.urology.2005.07.062
PMid:16399414
Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, et al. (2004). VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46: 293-298.
http://dx.doi.org/10.1016/j.lungcan.2004.04.037
PMid:15541813
Monzo M, Rosell R, Felip E, Astudillo J, et al. (1999). A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17: 2100-2104.
PMid:10561264
Mori A, Wada H, Nishimura Y, Okamoto T, et al. (2002). Expression of the antiapoptosis gene survivin in human leukemia. Int. J. Hematol. 75: 161-165.
http://dx.doi.org/10.1007/BF02982021
PMid:11939262
Plate KH, Breier G, Weich HA and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848.
http://dx.doi.org/10.1038/359845a0
PMid:1279432
Riedel F, Gotte K, Bergler W and Hormann K (2001). Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol. Rep. 8: 471-476.
PMid:11295065
Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A, et al. (2000). Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res. 60: 1815-1817.
PMid:10766164
Sato K, Sasaki R, Ogura Y, Shimoda N, et al. (1998). Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. Tohoku J. Exp. Med. 185: 173-184.
http://dx.doi.org/10.1620/tjem.185.173
PMid:9823778
Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, et al. (2003). Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res. 23: 3327-3331.
PMid:12926071
Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, et al. (2004). Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin. Chem. 50: 1425-1428.
http://dx.doi.org/10.1373/clinchem.2004.032003
PMid:15277352
Smith BD, Smith GL, Carter D, Sasaki CT, et al. (2000). Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 18: 2046-2052.
PMid:10811669
Suzuki A, Ito T, Kawano H, Hayashida M, et al. (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19: 1346-1353.
http://dx.doi.org/10.1038/sj.onc.1203429
PMid:10713676
Swana HS, Grossman D, Anthony JN, Weiss RM, et al. (1999). Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med. 341: 452-453.
http://dx.doi.org/10.1056/NEJM199908053410614
PMid:10438269
Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, et al. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49: 466-477.
http://dx.doi.org/10.1016/j.eururo.2005.12.031
PMid:16442208
Tran J, Rak J, Sheehan C, Saibil SD, et al. (1999). Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264: 781-788.
http://dx.doi.org/10.1006/bbrc.1999.1589
PMid:10544009
Waters WB (1996). Invasive bladder cancer - where do we go from here? J. Urol. 155: 1910-1911.
http://dx.doi.org/10.1016/S0022-5347(01)66044-0
Zhu H, Chen XP, Zhang WG, Luo SF, et al. (2005). Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. World J. Gastroenterol. 11: 3855-3859.
PMid:15991282